After adjusting for age, sex, ethnicity, smoking status, tumour grade, and clinical disease stage, we found that the high level of DNMT1 expression was associated with a 74% increased risk of death (HR, 1.74; 95% CI, 1.04–2.90). The gene discussed is DNMT1; the disease is neoplasm.